Resistant hypertension is, by definition, a challenge to most physicians treating hypertension. Renal sympathetic denervation has shown promising early results in treating this condition. The SYMPLICITY HTN-3 is the most recent trial to report the effects of this technique on resistant hypertension. This review discusses this study and its surprising neutral results before ending with an overview of key lessons learned
SYMPLICITY HTN 3: The death knell for renal denervation in hypertension? / Patel, Hitesh C; Hayward, Carl; Di Mario, Carlo. - In: GLOBAL CARDIOLOGY SCIENCE & PRACTICE. - ISSN 2305-7823. - ELETTRONICO. - 2014:(2014), pp. 15-20. [10.5339/gcsp.2014.15]
SYMPLICITY HTN 3: The death knell for renal denervation in hypertension?
Di Mario, Carlo
2014
Abstract
Resistant hypertension is, by definition, a challenge to most physicians treating hypertension. Renal sympathetic denervation has shown promising early results in treating this condition. The SYMPLICITY HTN-3 is the most recent trial to report the effects of this technique on resistant hypertension. This review discusses this study and its surprising neutral results before ending with an overview of key lessons learnedFile | Dimensione | Formato | |
---|---|---|---|
Patel HC -Symplicity NTH3-Global Cardiology Science & Prac 2014.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
278.53 kB
Formato
Adobe PDF
|
278.53 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.